Citibank: Adding Pharmaceutical Biotech (02269) to the 90-day upward catalyst watch list is expected to increase in the fourth quarter or annual guidelines

The Zhitong Finance App learned that Citi released a research report stating that Yao Ming Biotech (02269) was included in the 90-day upward catalyst watch list. The bank believes that the company may adjust its guidelines in the fourth quarter, and that the biosimilar drug development agreement reached with Fresenius may also prompt the company to raise its long-term goal of contract manufacturing organization (CMO) revenue. Citi said that Pharmaceutical Biotech is also its preferred AI-driven drug development (AIDD) beneficiary stock, and believes that the company's AIDD capabilities are being underestimated by the market.